Stay updated on Fremanezumab Subq for Migraine Preven Clinical Trial
Sign up to get notified when there's something new on the Fremanezumab Subq for Migraine Preven Clinical Trial page.

Latest updates to the Fremanezumab Subq for Migraine Preven Clinical Trial page
- Check3 days agoChange DetectedAn NIH funding attribution line '2015 ( U.S. NIH Grant/Contract )' has been added to the study's identifiers section. This addition records funding information for the study but does not change the study design, eligibility, or reported outcomes.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page revision tag was updated to v3.6.5, indicating a newer build of the page. This update likely represents minor maintenance or polish without altering study content.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page revision tag updated from v3.6.3 to v3.6.4, indicating a new internal revision of the page. This change does not alter the visible content or study details.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision: v3.6.3 is now displayed, replacing v3.6.2. This indicates a new release/build of the page rather than content changes.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous v3.6.0. This indicates a minor update to the page's software revision.SummaryDifference0.0%

- Check75 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', and new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) were added, with the Intervention/Treatment label updated and the revision tag raised to v3.6.0.SummaryDifference0.2%

Stay in the know with updates to Fremanezumab Subq for Migraine Preven Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fremanezumab Subq for Migraine Preven Clinical Trial page.